Illumina wants to bring liquid biopsy spinout Grail back in-...

Cancer diagnosis firm Grail could be re-joining Illumina, the company it was spun out of in 2016, despite filing for an initial public offering (IPO) just a few days ago.

Roche and Illumina forge genomics alliance for cancer testin...

DNA sequencers Illumina and PacBio call off $1.2bn merger

California-based DNA sequencing firms Illumina and Pacific Biosciences have called off their proposed $1.2 billion merger, after deciding that the transaction would be unlikely to make it p

Illumina picks UK site for biotech startup engine

Genomics firm Illumina is to foster biotech innovation in the UK by establishing a branch of its “Illumina Accelerator” in Cambridge.

Oxford Nanopore's tech reaches genome sequencing landmark

Oxford Nanopore one of many firms cutting time and cost of sequencing